Illumina (ILMN) Stock Price & AI Analysis

$80.90
$2.69
(3.44%)
Life Sciences Tools & Services

NASDAQ USA

May 16, 5:22 PM EDT
  • Market Cap.
    12.81B
  • Volume
    2.59M
  • Avg. Volume
    2.50M
  • Target Price
    $101.62
  • 52W Range
    68.70 - 156.66
  • RSI (14)
    54.42
  • Beta
    1.31
  • PEG Ratio
  • SMA 20
    5.03%
  • SMA 50
    2.03%
  • SMA 200
    -31.61%
  • Insider Owner
    2.88%
  • Insider Trans
    0.41%
  • Institution Owner
    97.27%
  • Institution Trans
    2.7%
  • Short Interest
    5.56%
  • EPS next Y
    10.79

Illumina Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm’s products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm’s products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Illumina | Latest news

Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this...

Insider Monkey - 2 days ago

Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue...

Review Illumina's (ILMN) international revenue performance and how it affects the predictions of...

Zacks - 3 days ago

Illumina First Quarter 2025 Earnings: EPS Beats Expectations

Illumina (NASDAQ:ILMN) First Quarter 2025 Results Key Financial Results Revenue: US$1.04b (down 3.3%...

Simply Wall St - 2 days ago

Morgan Stanley Lowers Illumina (NASDAQ:ILMN) Price Target to $100.00

Illumina (NASDAQ:ILMN – Get Free Report) had its price target dropped by Morgan Stanley from $136.00 to $100.00 in a research report issued on Monday,Benzinga reports. The firm currently has ...

ETF DAILY NEWS - 3 days ago

Illumina (NASDAQ:ILMN) Stock Price Down 5.4% After Analyst Downgrade

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price dropped 5.4% on Friday after JPMorgan Chase & Co. lowered their price target on the stock from $120.00 to $85.00. JPMorgan Chase ...

ETF DAILY NEWS - 7 days ago

Canaccord Genuity Group Cuts Illumina (NASDAQ:ILMN) Price Target to $87.00

Illumina (NASDAQ:ILMN – Free Report) had its target price trimmed by Canaccord Genuity Group from $92.00 to $87.00 in a report issued on Monday morning,Benzinga reports. The brokerage currently ...

ETF DAILY NEWS - 4 days ago

Traders Purchase Large Volume of Call Options on Illumina (NASDAQ:ILMN)

Illumina, Inc. (NASDAQ:ILMN – Get Free Report) saw some unusual options trading activity on Monday. Stock traders purchased 7,176 call options on the company. This represents an increase of ...

ETF DAILY NEWS - 3 days ago

Illumina price target lowered to $135 from $160 at Stifel

Stifel analyst Daniel Arias lowered the firm’s price target on Illumina (ILMN) to $135 from $160 and...

TipRanks - 6 days ago

Illumina, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will...

It's been a good week for Illumina, Inc. (NASDAQ:ILMN) shareholders, because the company has just...

Simply Wall St - 3 days ago

3 Volatile Stocks with Mounting Challenges

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes...

StockStory - 4 days ago